Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Gray, Emma K."'
Autor:
James, Nicholas D., Clarke, Noel W., Cook, Adrian, Ali, Adnan, Hoyle, Alex P., Attard, Gert, Brawley, Chris D., Chowdhury, Simon, Cross, William R., Dearnaley, David P., Bono, Johann S., Montana, Carlos Diaz, Gilbert, Duncan, Gillessen, Silke, Gilson, Clare, Jones, Rob J., Langley, Ruth E., Malik, Zafar I., Matheson, David J., Millman, Robin, Parker, Chris C., Pugh, Cheryl, Rush, Hannah, Russell, J. Martin, Berthold, Dominic R., Buckner, Michelle L., Mason, Malcolm D., Ritchie, Alastair W.S., Birtle, Alison J., Brock, Susannah J., Das, Prantik, Ford, Dan, Gale, Joanna, Grant, Warren, Gray, Emma K., Hoskin, Peter, Khan, Mohammad M., Manetta, Caroline, McPhail, Neil J., O'Sullivan, Joe M., Parikh, Omi, Perna, Carla, Pezaro, Carmel J., Protheroe, Andrew S., Robinson, Angus J., Rudman, Sarah M., Sheehan, Denise J., Srihari, Narayanan N., Syndikus, Isabel, Tanguay, Jacob, Thomas, Carys W., Vengalil, Salil, Wagstaff, John, Wylie, James P., Parmar, Mahesh K.B., Sydes, Matthew R.
Publikováno v:
James, N D, Clarke, N W, Cook, A, Ali, A, Hoyle, A P, Attard, G, Brawley, C D, Chowdhury, S, Cross, W R, Dearnaley, D P, Bono, J S, Montana, C D, Gilbert, D, Gillessen, S, Gilson, C, Jones, R J, Langley, R E, Malik, Z I, Matheson, D J, Millman, R, Parker, C C, Pugh, C, Rush, H, Russell, J M, Berthold, D R, Buckner, M L, Mason, M D, Ritchie, A WS, Birtle, A J, Brock, S J, Das, P, Ford, D, Gale, J, Grant, W, Gray, E K, Hoskin, P, Khan, M M, Manetta, C, McPhail, N J, O'Sullivan, J M, Parikh, O, Perna, C, Pezaro, C J, Protheroe, A S, Robinson, A J, Rudman, S M, Sheehan, D J, Srihari, N N, Syndikus, I, Tanguay, J, Thomas, C W, Vengalil, S, Wagstaff, J, Wylie, J P, Parmar, M KB & Sydes, M R 2022, ' Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476) ', International Journal of Cancer . https://doi.org/10.1002/ijc.34018
Abiraterone acetate plus prednisolone (AAP) previously demonstrated improved survival in STAMPEDE, a multi-arm, multi-stage platform trial in men starting long-term hormone therapy for prostate cancer. This long-term analysis in metastatic patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d41e4f972431efac3e44597e81d1a4a
https://pure.qub.ac.uk/en/publications/3adddebe-1d1a-4134-8495-5f087a1fee9e
https://pure.qub.ac.uk/en/publications/3adddebe-1d1a-4134-8495-5f087a1fee9e
Autor:
James ND; Division of Radiotherapy and Imaging, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK., Ingleby FC; MRC Clinical Trials Unit at University College London (UCL), Institute of Clinical Trials and Methodology, UCL, London, UK., Clarke NW; The Christie and Salford Royal Hospitals, Manchester, UK., Amos CL; MRC Clinical Trials Unit at University College London (UCL), Institute of Clinical Trials and Methodology, UCL, London, UK., Attard G; UCL Cancer Institute, London, UK., Brawley CD; MRC Clinical Trials Unit at University College London (UCL), Institute of Clinical Trials and Methodology, UCL, London, UK., Chowdhury S; Guy's and St. Thomas' NHS Foundation Trust, London, UK.; Sarah Cannon Research Institute, London, UK., Cross W; St James's University Hospital, Leeds, UK., Dearnaley DP; Division of Radiotherapy and Imaging, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK., Gilbert DC; MRC Clinical Trials Unit at University College London (UCL), Institute of Clinical Trials and Methodology, UCL, London, UK., Gillessen S; Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland., Jones RJ; Institute of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK., Langley RE; MRC Clinical Trials Unit at University College London (UCL), Institute of Clinical Trials and Methodology, UCL, London, UK., Macnair A; MRC Clinical Trials Unit at University College London (UCL), Institute of Clinical Trials and Methodology, UCL, London, UK.; Guy's and St. Thomas' NHS Foundation Trust, London, UK., Malik ZI; The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, UK., Mason MD; School of Medicine, Cardiff University, Cardiff, UK., Matheson DJ; Faculty of Education, Health and Wellbeing, University of Wolverhampton, Wolverhampton, UK., Millman R; MRC Clinical Trials Unit at University College London (UCL), Institute of Clinical Trials and Methodology, UCL, London, UK., Parker CC; Division of Radiotherapy and Imaging, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK., Rush HL; MRC Clinical Trials Unit at University College London (UCL), Institute of Clinical Trials and Methodology, UCL, London, UK.; Guy's and St. Thomas' NHS Foundation Trust, London, UK., Russell JM; Institute of Cancer Sciences, University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK., Au C; MRC Clinical Trials Unit at University College London (UCL), Institute of Clinical Trials and Methodology, UCL, London, UK., Ritchie AWS; Urology Department, Gloucestershire Royal NHS Foundation Trust, Gloucester, UK (retired)., Mestre RP; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Institute of Oncology Research (IOR), Bellinzona, Switzerland., Ahmed I; Southend University NHS Trust, Southend, UK., Birtle AJ; Rosemere Cancer Centre Lancs Teaching Hospitals, Preston, UK.; University of Manchester, Manchester, UK.; University of Central Lancashire (UCLan), Lancaster, UK., Brock SJ; University Hospital Dorset, Cardiff, UK., Das P; University Hospitals of Derby NHS Foundation Trust, Derby, UK., Ford VA; Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., Gray EK; Musgrove Park Hospital, Taunton, UK., Hughes RJ; Mount Vernon Cancer Centre, Cardiff, UK., Manetta CB; Sussex Cancer Centre, University Hospitals Sussex, Brighton, UK., McLaren DB; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK., Nikapota AD; Sussex Cancer Centre, University Hospitals Sussex, Brighton, UK.; Worthing and Southlands Hospital, Worthing, UK., O'Sullivan JM; Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK., Perna C; Royal Surrey NHS Foundation Trust, Guildford, UK., Peedell C; James Cook University Hospital, Middlesbrough, UK., Protheroe AS; Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Sundar S; Nottingham University Hospitals NHS Trust, Nottingham, UK., Tanguay JS; Velindre Cancer Centre, Cardiff, UK., Tolan SP; The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, UK., Wagstaff J; Swansea University College of Medicine & The South West Wales Cancer Centre, Swansea, UK., Wallace JB; Beatson West of Scotland Cancer Centre, Glasgow, UK., Wylie JP; The Christie NHS Foundation Trust, Manchester, UK., Zarkar A; University Hospitals Birmingham, UK., Parmar MKB; MRC Clinical Trials Unit at University College London (UCL), Institute of Clinical Trials and Methodology, UCL, London, UK., Sydes MR; MRC Clinical Trials Unit at University College London (UCL), Institute of Clinical Trials and Methodology, UCL, London, UK.
Publikováno v:
JNCI cancer spectrum [JNCI Cancer Spectr] 2022 Jul 01; Vol. 6 (4).
